Suchergebnisse - "Icht, Oded"

PubPharm (17)

1

SABR-Dual: A phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

enthalten in: ResearchSquare.com | 2024

von Fredman, E. | Icht, O. | Moore, A. | +4

2

SABR-Dual : a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

enthalten in: BMC cancer | 2024

von Fredman, E. | Icht, O. | Moore, A. | +4

3

SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

enthalten in: BMC cancer | 2024

von Fredman, E. | Icht, O. | Moore, A. | +4

4

Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment

enthalten in: Journal of neuro-oncology | 2024

von Averbuch, I. | Tschernichovsky, R. | Yust-Katz, S. | +11

5

Higher Toxicity Rates Following Hypofractionated Radiotherapy in Early Glottic Cancer Patients

enthalten in: ResearchSquare.com | 2023

von Zavdy, O. | Yosefof, E. | Shoffel-Havakuk, H. | +5

6

Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer : A large real-world cohort and review of the literature

enthalten in: Thoracic cancer | 2023

von Averbuch, I. | Tschernichovsky, R. | Icht, O. | +9

7

Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer : A Population-Based Cohort Study

enthalten in: The oncologist | 2023

von Icht, O. | Leader, A. | Batat, E. | +8

8

Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy

enthalten in: Frontiers in oncology | 2023

von Fredman, E. | Weinstock-Sabbah, M. | Icht, O. | +4

9

Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors

enthalten in: Journal of the neurological sciences | 2021

von Moore, A. | Yust-Katz, S. | Icht, O. | +8

10

Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Icht, O. | Darzi, N. | Shimony, S. | +13